Literature DB >> 20849292

Cross-talk between protein kinase A and the MAPK-activated protein kinases RSK1 and MK5.

Sergiy Kostenko1, Alexey Shiryaev, Gianina Dumitriu, Nancy Gerits, Ugo Moens.   

Abstract

Typical mammalian mitogen-activated protein kinase (MAPK) pathways consist of a cascade of three consecutive phosphorylation events exerted by a MAPK kinase kinase (MAPKKK), a MAPK kinase (MAPKK), and finally a MAPK. MAPKs not only target non-protein kinase substrates, they can also phosphorylate other protein kinases designated as MAPK-activated protein kinases (MAPKAPK). The MAPKAPK family includes the ribosomal-S6-kinases (RSK1-4), the MAPK-interacting kinases (MNK1 and 2), the mitogen-and stress-activated kinases (MSK1 and 2), and the MAPKAPK (MK2, 3, and 5) subfamilies. Although several reports indicate extensive cross-talk between the MAPK and protein kinase A (PKA) pathways, evidence of a direct interaction at the level of the MAPKAPK only appeared recently. The MAPKAPKs RSK1 and MK5 can bind to PKA, but the features of these interactions are distinct. This review discusses the different characteristics of regulating the activity and subcellular localization of MK5 and RSK1 by PKA and the functional implications of these interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849292     DOI: 10.3109/10799893.2010.515593

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  6 in total

1.  A Role for cAMP and Protein Kinase A in Experimental Necrotizing Enterocolitis.

Authors:  Brian P Blackwood; Douglas R Wood; Carrie Yuan; Joseph Nicolas; Isabelle G De Plaen; Kathryn N Farrow; Pauline Chou; Jerrold R Turner; Catherine J Hunter
Journal:  Am J Pathol       Date:  2016-12-08       Impact factor: 4.307

2.  Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells.

Authors:  Lan Deng; Ling Jiang; Xianghua Lin; Kuo-Fu Tseng; Zhigang Lu; Xiuju Wang
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

3.  Comparative molecular dynamics simulations of mitogen-activated protein kinase-activated protein kinase 5.

Authors:  Inger Lindin; Yimingjiang Wuxiuer; Aina Westrheim Ravna; Ugo Moens; Ingebrigt Sylte
Journal:  Int J Mol Sci       Date:  2014-03-19       Impact factor: 5.923

Review 4.  Targeting protein kinase A in cancer therapy: an update.

Authors:  Luigi Sapio; Francesca Di Maiolo; Michela Illiano; Antonietta Esposito; Emilio Chiosi; Annamaria Spina; Silvio Naviglio
Journal:  EXCLI J       Date:  2014-08-18       Impact factor: 4.068

5.  Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest.

Authors:  Lucija Belužić; Ivana Grbeša; Robert Belužić; Jong Hoon Park; Hyun Kyung Kong; Nevenka Kopjar; Guadalupe Espadas; Eduard Sabidó; Adriana Lepur; Filip Rokić; Ivanka Jerić; Lidija Brkljačić; Oliver Vugrek
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

Review 6.  The Molecular Basis for Specificity at the Level of the Protein Kinase a Catalytic Subunit.

Authors:  Kristoffer Søberg; Bjørn Steen Skålhegg
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-12       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.